2025-01-20 15-26-43 |
- The difference between 1 preinjury fast day and 2.5 preinjury fast days in benjaminFastingInducesHighly2022 - Figure 1C is statistically significant
|
2025-01-20 15-27-11 |
- The difference between 2 preinjury fast days and 2.5 preinjury fast days in benjaminFastingInducesHighly2022 - Figure 1C is statistically significant
|
2025-01-20 15-30-48 |
- There is no difference between 1 preinjury fast day and 2 preinjury fast days in benjaminFastingInducesHighly2022 - Figure 1C
|
2025-01-20 15-36-05 |
- Every measurement of "days" in benjaminFastingInducesHighly2022 corresponds to exactly 24 hours per day measured
|
2025-01-20 16-30-30 |
- A Keto-Mojo meter was used to measure blood glucose in benjaminFastingInducesHighly2022
|
2025-01-20 16-43-48 |
- Mice in the Ketogenic Diet group continued to be fed a ketogenic diet during the 7 days following injury prior to sacrifice in benjaminFastingInducesHighly2022
|
2025-01-20 16-49-31 |
|
2025-01-20 20-25-36 |
- The difference between groups in benjaminFastingInducesHighly2022 - Figure 2F is statistically significant
|
2025-01-28 18-41-13 |
- All calculations in melendez-heviaWeakLinkMetabolism2009 were performed for a person weighing 70 kg
|
2025-01-28 20-48-01 |
|
2025-01-28 20-48-16 |
- % changes in circulating IGF1 levels act as an adequate proxy for assessing changes in IGF1 availability
|
2025-01-28 20-49-14 |
- A Von Frey test is an appropriate test for assessing pain for knee Osteoarthritis in mice
|
2025-01-28 20-49-56 |
|
2025-01-28 20-50-38 |
|
2025-01-28 20-51-20 |
|
2025-01-28 20-52-50 |
|
2025-01-28 20-53-52 |
|
2025-01-28 21-01-20 |
|
2025-01-28 21-01-34 |
- Constriction of the Sciatic Nerve causes pain in similar ways in both mice and humans
|
2025-01-28 21-02-13 |
- BrdU is an adequate marker of cell proliferation
|
2025-01-28 21-02-30 |
|
2025-01-28 21-03-50 |
|
2025-01-28 21-05-34 |
- Intraperitoneal injection of Urolithin A in mice will result in higher bioavailability than an equivalent dose taken by mouth in humans
|
2025-01-28 21-07-52 |
|
2025-01-28 21-08-35 |
|
2025-01-28 21-10-33 |
|
2025-01-28 21-10-51 |
|
2025-01-28 21-11-20 |
- The behavioral tests used in wangUrolithinAlleviatesNeuropathic2023 are appropriate for assessing pain from constriction of the Sciatic Nerve
|
2025-01-28 21-11-25 |
- The average cell dose in centenoTreatmentLumbarDegenerative2017 did not take into account any patient who had multiple injections
|
2025-01-28 21-12-39 |
|
2025-01-28 21-13-21 |
|
2025-01-28 21-16-06 |
- The difference between the control group and the 250 mg/kg/day group in damicoUrolithinImprovesMitochondrial2022 - Figure 4D would be statistically significant if they used larger cohorts
|
2025-01-28 21-16-36 |
- The knee Sinovitis observed in the model of knee Osteoarthritis in damicoUrolithinImprovesMitochondrial2022 is relevant to humans
|
2025-01-28 21-17-02 |
- The difference between the control group and the 250 mg/kg/day group treated with a 4g filament in damicoUrolithinImprovesMitochondrial2022 - Figure 4A would be statistically significant if they used larger cohorts
|
2025-01-28 21-17-31 |
- The difference between the control group and the 250 mg/kg/day group treated with a 4g filament in damicoUrolithinImprovesMitochondrial2022 - Figure 4B would be statistically significant if they used larger cohorts
|
2025-01-28 21-18-31 |
- The difference between the control group and the 50 mg/kg/day group treated with a 4g filament in damicoUrolithinImprovesMitochondrial2022 - Figure 4B would be statistically significant if they used larger cohorts
|
2025-01-28 21-19-18 |
|
2025-01-28 21-20-02 |
|
2025-01-28 21-20-26 |
- The human-equivalent dose for mouse data from usfdaEstimatingMaximumSafe2018 is relevant to all compounds
|
2025-01-28 21-20-46 |
- The human-equivalent dose for rat data from usfdaEstimatingMaximumSafe2018 is relevant to all compounds
|
2025-01-28 21-21-27 |
|
2025-01-28 21-23-03 |
|
2025-01-28 21-24-08 |
|
2025-01-28 21-24-12 |
- The maximum food intake by rats in whiteEffectsAgeFeeding2000 would have been 22-23 grams per day for the age range between between the two ranges tested if it were monitored
|
2025-01-28 21-24-30 |
- The mean FRI change scores in Table 1 of centenoTreatmentLumbarDegenerative2017 are all negative values
|
2025-01-28 21-24-43 |
- The mean NPS change scores in Table 1 of centenoTreatmentLumbarDegenerative2017 are all negative values
|
2025-01-28 21-25-18 |
|
2025-01-28 21-25-34 |
- The mice in chengProlongedFastingReduces2014 underwent 72 hours of Prolonged Fasting when their tissues were harvested unless explicitly stated otherwise.
|
2025-01-28 21-26-33 |
- The mouse Fasting-Mimicking Diet (FMD) used in longoUtilizationFastingMimickingDiet2023 was the same as the mouse FMD used in brandhorstPeriodicDietThat2015
|
2025-01-28 21-28-50 |
|
2025-01-28 21-29-23 |
|
2025-01-28 21-31-00 |
|
2025-01-28 21-31-22 |
- The progression of pain from knee Osteoarthritis in mice in damicoUrolithinImprovesMitochondrial2022 is similar to that of humans
|
2025-01-28 21-31-23 |
|
2025-01-28 21-31-35 |
|
2025-01-28 21-32-52 |
|
2025-01-28 21-34-31 |
- The progression of knee Osteoarthritis in damicoUrolithinImprovesMitochondrial2022 is similar to that of humans
|
2025-01-28 21-35-03 |
|
2025-01-28 21-35-29 |
- The pre-injection epidural injection of Platelet Lysate (PL) had no meaningful impact on the measured outcomes in centenoTreatmentLumbarDegenerative2017
|
2025-01-28 21-36-20 |
- The post-injection epidural injection of Platelet Lysate (PL) had no meaningful impact on the measured outcomes in centenoTreatmentLumbarDegenerative2017
|
2025-01-28 21-36-55 |
|
2025-01-29 09-33-38 |
|
2025-01-29 09-33-55 |
- The results for cas3+ cells in figure 1C of the longoUtilizationFastingMimickingDiet2023 patent would be the same during a Fasting-Mimicking Diet (FMD) cycle as they are shown at the end of an FMD cycle
|
2025-01-29 09-34-34 |
- The results for cas3+ cells in figure 1C of the longoUtilizationFastingMimickingDiet2023 patent would be the same regardless of the number of consecutive Fasting-Mimicking Diet (FMD) cycles performed
|
2025-01-29 09-35-00 |
- The results for cas3+p16+ cells in figure 1D of the longoUtilizationFastingMimickingDiet2023 patent would be the same during a Fasting-Mimicking Diet (FMD) cycle as they are shown at the end of an FMD cycle
|
2025-01-29 09-35-27 |
- The results for cas3+p16+ cells in figure 1D of the longoUtilizationFastingMimickingDiet2023 patent would be the same regardless of the number of consecutive Fasting-Mimicking Diet (FMD) cycles performed
|
2025-01-29 09-35-44 |
- The results for lean mass in 28-month-old mice in brandhorstPeriodicDietThat2015 - Figure 1I would hold true for mice at any age
|
2025-01-29 09-36-02 |
- The results for lean mass in 28-month-old mice in the brandhorstPeriodicDietThat2015 - Figure 1I would hold true for mice after any number of Fasting-Mimicking Diet (FMD) cycles
|
2025-01-29 09-36-29 |
|
2025-01-29 09-37-15 |
|
2025-01-29 09-37-53 |
- The results of patents are reliable even though they are not peer-reviewed
|
2025-01-29 09-39-30 |
- The results shown in benjaminFastingInducesHighly2022 - Figure 1C are due specifically to blood Beta-Hydroxybutyrate (BHB) levels and not to other physiological changes that occur during fasting
|
2025-01-29 09-39-49 |
- The statistical significance label for the UA group in shiUrolithinAlleviatesOxidative2021 - Figure 7D is comparing the UA group to the IDD group, not an H2O2 group as suggested by the figure description
|
2025-01-29 09-39-53 |
- The statistical significance label for the UA group in shiUrolithinAlleviatesOxidative2021 - Figure 7B is comparing the UA group to the IDD group, not an H2O2 group as suggested by the figure description
|
2025-01-29 09-40-30 |
- The statistical significance label for the UA group in shiUrolithinAlleviatesOxidative2021 - Figure 8B is comparing the UA group to the IDD group, not an H2O2 group as suggested by the figure description
|
2025-01-29 09-40-51 |
- The statistical significance label for the UA group in shiUrolithinAlleviatesOxidative2021 - Figure 8D is comparing the UA group to the IDD group, not an H2O2 group as suggested by the figure description
|
2025-01-29 09-41-08 |
- The statistical significance label for the UA group in shiUrolithinAlleviatesOxidative2021 - Figure 8E is comparing the UA group to the IDD group, not an H2O2 group as suggested by the figure description
|
2025-01-29 09-41-42 |
|
2025-01-29 09-41-58 |
- The total number of CD45+ cells is no different between groups in chengProlongedFastingReduces2014 -figure 5C
|
2025-01-29 09-42-22 |
- The total number of cells in the bone marrow of 20.5-month-old is no different than that of 8-10-month-old mice
|
2025-01-29 09-42-39 |
- The total number of cells in the bone marrow of 20.5-month-old mice were no different between control and FMD groups in the brandhorstPeriodicDietThat2015 study
|
2025-01-29 09-45-39 |
- p16+ LT-HSCs did not differentiate into other cells (e.g. p16+ ST-HSCs or p16+ MPPs) in 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles in longoUtilizationFastingMimickingDiet2023 - Figure 1D
|
2025-01-29 09-46-09 |
- p16 is a marker of senescence in humans
|
2025-01-29 09-46-50 |
- The total number of cells in the bone marrow of FMD-treated mice and age-matched controls is no different in brandhorstPeriodicDietThat2015 - Figure 2T
|
2025-01-29 09-46-53 |
- There is a human equivalent of the FMD administered to mice in the brandhorstPeriodicDietThat2015 study
|
2025-01-29 09-46-59 |
- There were 2 patients who received intradiscal injection of MSCs into both the L5-S1 and L4-L5 discs in orozcoIntervertebralDiscRepair2011
|
2025-01-29 09-47-38 |
- Urolithin A was dosed as mg/kg of body weight in damicoUrolithinImprovesMitochondrial2022
|
2025-01-29 09-47-47 |
- Urolithin A was dosed as mg/kg of body weight in linUrolithinAinducedMitophagy2020
|
2025-01-29 09-47-53 |
- Urolithin A was dosed as mg/kg of body weight in shiUrolithinAlleviatesOxidative2021
|
2025-01-29 09-48-06 |
- There is a human equivalent of the FMD administered to mice in the longoUtilizationFastingMimickingDiet2023 patent
|
2025-01-29 09-50-38 |
- cas3 is a marker of apoptosis in human cells
|
2025-01-29 09-50-41 |
- p16 accumulates in human cells the same way it does in mouse cells
|
2025-01-31 15-13-30 |
|
2025-02-02 15-02-59 |
|